Cargando…
PD-L1 aptamer-functionalized degradable hafnium oxide nanoparticles for near infrared-II diagnostic imaging and radiosensitization
Immune checkpoint blockade is now recognized as a paradigm-shifting cancer therapeutic strategy, whereas there remains difficulty in accurately predicting immunotherapy efficacy by PD-L1 expression. In addition, radiotherapy for cancer patients faces the problem of insufficient dose of radiotherapy...
Autores principales: | Wei, Min, Shen, Xiao, Fan, Xueqi, Li, Jiwei, Bai, Jingwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282151/ https://www.ncbi.nlm.nih.gov/pubmed/37351473 http://dx.doi.org/10.3389/fbioe.2023.1224339 |
Ejemplares similares
-
Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer
por: Deng, Guozhen, et al.
Publicado: (2023) -
Near-Infrared Light-Triggered Photodynamic Therapy and Apoptosis Using Upconversion Nanoparticles With Dual Photosensitizers
por: Lee, Song Yeul, et al.
Publicado: (2020) -
Encapsulation-Dependent Enhanced Emission of Near-Infrared Nanoparticles Using in vivo Three-Photon Fluorescence Imaging
por: Du, Ye, et al.
Publicado: (2020) -
Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
por: Hu, Pengcheng, et al.
Publicado: (2019) -
Near-Infrared Responsive Phase-Shifted Nanoparticles for Magnetically Targeted MR/US Imaging and Photothermal Therapy of Cancer
por: Xu, Yan, et al.
Publicado: (2020)